10 News reports Australians are ending up in hospital after using unregulated peptides, prompting warnings from two state health departments.
Recap by typeshit. Post by @10newsau on Instagram.
NewsNation reports doctors' guidance on pausing GLP-1 medications ahead of pregnancy. The full story has their reasoning.
The piece examines claims that taking smaller GLP-1 doses brings weight loss with fewer side effects, and asks how well that holds up.
A former peptide chemist covered the AAPM conference as the FDA weighs letting pharmacies compound BPC-157 and others, and found sizable gaps in the evidence advocates cite.
IE Lifestyle reports on new research tying GLP-1 use to nail and hair problems, with two experts weighing in on the findings.
The $49 virtual weight management visits now cover insurance checks and Medicare GLP-1 Bridge support, with pharmacists contacting everyone who starts a fill.
A University of Pennsylvania mouse study found on-off GLP-1 use left mice 20 per cent heavier than those kept on the drug, and doctors warn human effects are unknown.
Loading…